Health Catalyst CEO tax-withholding share sale filed

Health Catalyst, Inc. CEO Albert Benjamin reported a mandated tax-related share disposition.

Rhea-AI Filing Summary

Health Catalyst, Inc. CEO Albert Benjamin reported a mandated tax-related share disposition. On June 10, 2026, 34,485 shares of common stock were used to cover tax withholding obligations tied to vesting of restricted stock units at an average price of $1.6918 per share. After this non-discretionary “sell to cover” transaction, he held 1,423,971 shares directly.

Insider Trade Summary

Exercise Price or Tax Liability: 34,485 shares

Exercise Price or Tax Liability 1 txn

Insider Albert Benjamin

Role CEO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	34,485	$1.6918	$58K

Holdings After Transaction: Common Stock — 1,423,971 shares (Direct)

Footnotes (1)

1. F1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Key Figures

Tax-withholding shares: 34,485 shares Average disposition price: $1.6918 per share Shares held after transaction: 1,423,971 shares

3 metrics

Tax-withholding shares 34,485 shares Common stock used to cover tax obligations from RSU vesting

Average disposition price $1.6918 per share Price for tax-withholding disposition on June 10, 2026

Shares held after transaction 1,423,971 shares CEO’s direct common stock holdings following tax-withholding event

Key Terms

Restricted Stock Units, tax withholding obligations, sell to cover

3 terms

Restricted Stock Units financial

"in connection with the vesting of Issuer's Restricted Stock Units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"to cover tax withholding obligations in connection with the vesting"

sell to cover financial

"funded by a "sell to cover" transaction and does not represent"

Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Health Catalyst (HCAT) report for CEO Albert Benjamin?

Health Catalyst CEO Albert Benjamin reported a tax-related share disposition. 34,485 common shares were used to cover tax withholding obligations from vesting restricted stock units, under a mandated “sell to cover” arrangement, rather than a discretionary open-market sale.

How many Health Catalyst (HCAT) shares did the CEO use for tax withholding?

Albert Benjamin used 34,485 Health Catalyst common shares for tax withholding. These shares covered taxes arising from vesting restricted stock units, according to the company’s equity incentive plan rules requiring a non-discretionary “sell to cover” transaction.

At what price were Health Catalyst (HCAT) shares applied to the CEO’s tax obligations?

The shares were applied at an average price of $1.6918 per share. This price was used for the 34,485 shares disposed to satisfy tax withholding obligations related to the vesting of the CEO’s restricted stock units.

How many Health Catalyst (HCAT) shares does the CEO hold after this Form 4 transaction?

After the reported transaction, CEO Albert Benjamin directly holds 1,423,971 Health Catalyst common shares. This figure reflects his position following the tax-withholding disposition that used 34,485 shares to satisfy obligations from restricted stock unit vesting.

Was the Health Catalyst (HCAT) CEO’s Form 4 transaction a discretionary stock sale?

No, the CEO’s transaction was not discretionary. The footnote explains the shares were required to be sold to cover tax withholding obligations under the company’s equity incentive plans, as a mandated “sell to cover” transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 04:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Albert Benjamin

(Last) (First) (Middle)

10897 S. RIVER FRONT PARKWAY

SUITE 300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		F		34,485(1)	D	$1.6918	1,423,971	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Remarks:

	/s/ Benjamin Landry, as Attorney-in-Fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)